Trends of Buprenorphine Prescribing for Opioid Dependence Before, and During the Early and Later Part of the COVID-19: A Study from a Large Publicly-Funded Opioid Agonist Treatment Services in India
Background:
The COVID-19 pandemic has impacted how people access medications for opioid dependence. Researchers looked at monthly changes in several factors related to buprenorphine/naloxone (BNX) treatment over 56 months, including...